NCT06539260CompletedEarly phase 1
Clinical Relationship Between Vitamin D-mediated Th17 and Treg Cells and Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 26 Aug 2024
Brief summary (registry, in English)
The aim of this study is to detect the expression levels of vitamin D, Treg, and Th17 in the peripheral blood of patients with Parkinson\'s disease (PD), investigate the impact of Treg/Th17 imbalance on PD patients, and explore the effects of vitamin D intervention on Treg/Th17 imbalance and clinical outcomes. Furthermore, this study aims to delve into the potential mechanisms of vitamin D deficiency and Treg/Th17 imbalance in the pathogenesis of Parkinson\'s disease, ultimately providing new theoretical evidence for the research, prevention, and treatment of PD.
- Status (registry)
- Completed
- Phase (registry)
- Early phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 1 Aug 2024
- Start date
- 1 Jan 2023
- Primary completion date
- 1 Jul 2024
- Lead sponsor
- Suzhou Municipal Hospital of Anhui Province
- Diseases
- Parkinson disease
- NCT number
- NCT06539260
What you commit to
- Study type: Interventional · Early phase 1
- Participants enrolled: 30
- From 1 Jan 2023 to the primary completion date, 1 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Have related vitamin D metabolic diseases (kidney failure, severe liver damage, hereditary 1α hydroxylase deficiency, etc.).
- Have an immune system disorder.
- Have a history of disabling cerebrovascular disease.
- Have severe dementia, depression, or serious mental illness.
- Failure to sign the informed consent form.
Other
- Have a grade 1 or 2 relative with PD.
Who the study is looking for
- Meets the age requirement and is in good health.
Age in the registry: 45 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Suzhou Hospital of Anhui Medical University Coordinator of this site? Confirm its status | Suzhou | China | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.